Healthcare -
Biotechnology - NASDAQ - US
$ 0.023
-0.87 %
$ 914 K
Market Cap
-0.02
P/E
VIRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities VIRX - Viracta Therapeutics, Inc.
438 K
LAST VALUE
-91.62%
2 YEAR CAGR
-41.41%
5 YEAR CAGR
-22.20%
10 YEAR CAGR